Vebicorvir (ABI-H0731) 是一种乙型肝炎病毒 (HBV) 核心蛋白抑制剂。Vebicorvir (ABI-H0731) 在两种感染模型中共价抑制 cccDNA,EC50 值范围为 1.84 至 7.3 μM。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Vebicorvir, also known as ABI-H0731, is a first-generation hepatitis B virus (HBV) core protein inhibitor.Vebicorvir inhibits covalent closed-circle DNA (cccDNA) formation in two models of de novo infection, with EC50s ranging from 1.84 μM to 7.3 μM.Vebicorvir inhibits pgRNA, HBeAg and HBsAg production with EC50 values of 2.68 μM, 4.95 μM, and 7.30 μM, respectively.Vebicorvir is an inhibitor of pgRNA encapsulation and rcDNA synthesis[1]. |
Animal study | Administered intravenously, Vebicorvir rapidly distributes and decays in a biphasic manner in all subject species. In mice, rats, dogs and monkeys, the plasma clearance of Vebicorvir was 8.05, 10.1, 14.7 and 4.86 ml/min/kg, representing 9%, 16%, 47% and 11% of hepatic blood flow, respectively[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.14mL 0.43mL 0.21mL |
10.70mL 2.14mL 1.07mL |
21.39mL 4.28mL 2.14mL |
CAS号 | 2090064-66-5 |
分子式 | C19H12F3N3O4S2 |
分子量 | 467.442 |
别名 | ABI-H0731 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(224.63 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |